Currently, many in the health science industry treat pharmaceuticals as if they will work similarly across a broad population. However, the data on drugs in use contradict this approach, with many treatments proving to be ineffective for high percentages of patients. But precision (or personalized) medicines are roaring onto the scene. As of 2020, 286 personalized medicines were available, a rapid growth considering that only 5 personalized medicines were accessible in 2008. And experts predict CAGR of nearly 12% through 2027.

Precision medicine is an exciting and evolving field promising better targeted therapeutics for patient populations. By collecting a large amount of data, including multiomic panels, lifestyle, and environmental information, then analyzing it, drug developers can better predict the efficacy of biopharmaceutical interventions in specific populations.

This article provides insight and data to help sponsors and research organizations understand the current state of precision medicine. As a newer field, its impact on clinical research and clinical care are still unfolding.

Download the guide to discover:

  • Why clinical trials are affected and must change
  • How clinical trial designs are different for precision medicine
  • How clinical trial recruitment and retention are different for precision studies
  • The main challenges to the adoption of precision medicine
  • The future technology necessary for precision medicine and its promise for patients